To view the PDF file, sign up for a MySharenet subscription.

ADVANCED HEALTH LIMITED - Trading Statement

Release Date: 14/02/2017 15:30
Code(s): AVL     PDF:  
Wrap Text
Trading Statement

ADVANCED HEALTH LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 2013/059246/06)
(“the Company” or “Advanced Health”)
ISIN Code: ZAE000189049            JSE Code: AVL


TRADING STATEMENT


In terms of paragraph 3.4(b)(i) of the Listings Requirements of the Johannesburg Stock Exchange, listed
companies are required to publish a trading statement as soon as they become reasonably certain that the
financial results for the next period to be reported on will differ by more than 20% from those of the
previous corresponding period.

Shareholders are referred to the initial trading statement released on SENS on Wednesday,
30 November 2016 and are advised that Advanced Health expects to report a net loss after taxation
attributable to the parent as per the unaudited financial results for the six months ended
31 December 2016, of R23.311 million compared to a profit of R0.925 million for the comparative period
ended 31 December 2015.

The Company expects a loss per share and a headline loss per share of 10.52 and 10.52 cents respectively
for the six months ended 31 December 2016 compared to earnings per share and headline earnings per
share of 0.42 and 0.51 cents for the six months ended 31 December 2015.

The decrease in earnings is planned and in accordance with the Company rolling out its known strategy to
become the leading provider of day hospitals in South Africa and Australia. In South Africa, the group now
consists of ten operational day hospitals. The last one of these became operational in eMalahleni towards
the end of January 2017. In Australia the flagship of the group, which has got six theatres, became
operational during January 2016. The company is starting to see an increase in the number of patients
treated and consequently turnover in both South Africa and Australia is increasing. In South Africa, the
substantial increases in medical scheme contributions, for 2017, should trigger greater utilisation of day
hospitals.

The information in this trading statement has not been reviewed and reported on by the Company’s
auditors.

The Company’s interim results for the six months ended 31 December 2016 are anticipated to be released
on or about the 22 February 2017.


Johannesburg
14 February 2017

Designated Advisor
Grindrod Bank Limited

Date: 14/02/2017 03:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story